Biotech · Public company · Waltham, MA, US
Repligen Corp
Ticker RGEN · SEC CIK 0000730272
Track this companyFree. Adds Repligen Corp to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Clinical trials2
- Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor ConspicuityEARLY_PHASE1 · WITHDRAWN · started Jun 1, 2011ClinicalTrials.gov NCT01371240 · fetched Nov 12, 2026
- Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive DisorderPHASE2 · COMPLETED · started Feb 1, 2005ClinicalTrials.gov NCT00216294 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Nov 6, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Oct 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 27, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 15, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 8, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Jul 29, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 28, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 22, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 15, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 6, 2026 · fetched Nov 12, 2026